In a research report issued Friday, Cantor Fitzgerald analyst Caroline Corner initiated coverage on shares of StemCells Inc (NASDAQ:STEM) with a Buy rating and price …
Jason Kolbert of Maxim Group rates stocks in the biotechnology sector and he’s ranked #2811 out of 3602 analysts on TipRanks. Yesterday, Kolbert made two news …
In a research report sent to investors today, Maxim’s healthcare analyst Jason Kolbert maintained a Buy rating on StemCells (NASDAQ:STEM) with a $5 price …
Maxim Group analyst Jason Kolbert maintained a Buy rating on StemCells (NASDAQ:STEM) with a price target of $5.00, as the company reported results for 3Q14 …
In a research report issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on StemCells Inc (NASDAQ:STEM) with a $5 price …
